Putri, A.D.; Chen, P.-S.; Su, Y.-L.; Lin, J.-P.; Liou, J.-P.; Hsieh, C.-M.
Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy. Pharmaceutics 2021, 13, 1728.
https://doi.org/10.3390/pharmaceutics13101728
AMA Style
Putri AD, Chen P-S, Su Y-L, Lin J-P, Liou J-P, Hsieh C-M.
Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy. Pharmaceutics. 2021; 13(10):1728.
https://doi.org/10.3390/pharmaceutics13101728
Chicago/Turabian Style
Putri, Athika Darumas, Pai-Shan Chen, Yu-Lin Su, Jia-Pei Lin, Jing-Ping Liou, and Chien-Ming Hsieh.
2021. "Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy" Pharmaceutics 13, no. 10: 1728.
https://doi.org/10.3390/pharmaceutics13101728
APA Style
Putri, A. D., Chen, P. -S., Su, Y. -L., Lin, J. -P., Liou, J. -P., & Hsieh, C. -M.
(2021). Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy. Pharmaceutics, 13(10), 1728.
https://doi.org/10.3390/pharmaceutics13101728